Despite mistrust of the pharmaceutical industry, most people who participate in clinical trials are willing to have their data shared with researchers who work at drug companies, although concerns remain that the information may be used for marketing purposes, according to a new study.
Specifically, 44 percent of clinical trial participants who were queried indicated that they have little to no trust in drug makers, yet overall, 82 percent said they were very or somewhat likely to allow scientists at for-profit companies to access their data.
About the Author Reprints
